Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
BIRC6 encodes a protein with a BIR (baculoviral inhibition of apoptosis protein repeat) domain and a UBCc (ubiquitin-conjugating enzyme E2, catalytic) domain. Zusätzlich bieten wir Ihnen BIRC6 Kits (9) und und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 68 products:
Human Polyclonal BIRC6 Primary Antibody für ICC, IF - ABIN4284734
Dong, Lin, Low, Vucic, English, Yee, Murray, Lam, Ling, Lam, Gout, Wang: Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013
Show all 4 Pubmed References
Cow (Bovine) Polyclonal BIRC6 Primary Antibody für ELISA, ICC - ABIN4284735
Lopergolo, Pennati, Gandellini, Orlotti, Poma, Daidone, Folini, Zaffaroni: Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation. in British journal of cancer 2009
Dog (Canine) Monoclonal BIRC6 Primary Antibody für IF, WB - ABIN968408
Hauser, Bardroff, Pyrowolakis, Jentsch: A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. in The Journal of cell biology 1998
Human Polyclonal BIRC6 Primary Antibody für ICC, IF - ABIN152603
Aharinejad, Andrukhova, Lucas, Zuckermann, Wieselthaler, Wolner, Grimm: Programmed cell death in idiopathic dilated cardiomyopathy is mediated by suppression of the apoptosis inhibitor Apollon. in The Annals of thoracic surgery 2008
BIRC6 targeting inhibited the growth of enzalutamide-resistant castration-resistant prostate cancer models and may represent a new option for clinical treatment of advanced, enzalutamide-resistant prostate cancer
AVEN (zeige AVEN Antikörper) and BIRC6 are inhibited by combination therapy of miR (zeige MLXIP Antikörper)-30e and proanthocyanidin in glioblastoma stem cells
Apollon expression is associated with the biological characteristics of esophageal squamous cell carcinoma (ESCC), and may be a valuable prognostic factor and a novel chemotherapeutic target for ESCC treatment.
Apollon role in the multidrug resistance of human chronic myelogenous leukemia cells
Apollon gene silencing can induce apoptosis and growth impairment in HeLa cells. In this regard, apollon can be considered a candidate therapeutic target in HeLa cells as a positive human papillomavirus cancer cell line.
BRUCE protein was detected in 82% of tumors and tumor progression stage and invasion depth correlated significantly with BRUCE protein expression
Results show that in addition to the scaffolding function in complex formation, BRUCE has an E3 ligase function to promote BRIT1 (zeige MCPH1 Antikörper) deubiquitination by USP8 (zeige USP8 Antikörper) leading to accumulation of BRIT1 (zeige MCPH1 Antikörper) at DNA double-strand break.
BIRC6 overexpression is a predictor of poor prognosis in colorectal cancer and could be a potential target for colorectal cancer therapy.
The study demonstrates that the T allele of the rs2754511 in the BIRC6 gene plays a protective role in pseudoexfoliative glaucoma patients of the Pakistani population.
Humanin signaling pathway via htHNR/JAKs/STAT3 (zeige STAT3 Antikörper) increased the expression levels of mRNA and protein of Apollon/Bruce, an unusual member of the inhibitors of apoptosis proteins
The results of this study reveal the importance of BIRC6 expression for embryo survival during bovine preimplantation embryo development.
BRUCE acts as a scaffold, bridging the ubiquitin-specific peptidase 8 (USP8 (zeige USP8 Antikörper)) and BRIT1 (zeige MCPH1 Antikörper) in a complex to coordinate USP8 (zeige USP8 Antikörper)-catalyzed deubiquitination of BRIT1 (zeige MCPH1 Antikörper).
BRUCE protects cells against apoptosis and functions as an inhibitor of apoptosis.
BRUCE is broadly expressed in embryonic, extraembryonic, and adult mouse tissues, this bifunctional protein might play a unique role in normal trophoblast differentiation and embryonic survival
p53 (zeige TP53 Antikörper) is a downstream effector of Bruce, and, in response to loss of Bruce function, p53 (zeige TP53 Antikörper) activates Pidd (zeige PIDD Antikörper)/caspase-2 (zeige CASP2 Antikörper) and Bax (zeige BAX Antikörper)/Bak (zeige BAK1 Antikörper), leading to mitochondrial apoptosis
Birc6 plays a role in cell division
These results establish a previously unrecognized link between NFAT (zeige NFATC1 Antikörper) signaling and regulation of IAP (zeige ALPI Antikörper) expression and are the first to identify a signaling pathway that increases BRUCE expression.
This gene encodes a protein with a BIR (baculoviral inhibition of apoptosis protein repeat) domain and a UBCc (ubiquitin-conjugating enzyme E2, catalytic) domain. This protein inhibits apoptosis by facilitating the degradation of apoptotic proteins by ubiquitination.
BIR repeat-containing ubiquitin-conjugating enzyme
, baculoviral IAP repeat-containing 6
, baculoviral IAP repeat-containing protein 6
, ubiquitin-conjugating BIR domain enzyme apollon
, ubiquitin-conjugating BIR-domain enzyme apollon
, baculoviral IAP repeat-containing 6 (apollon)
, baculovirus inhibitor of apoptosis repeat containing ubiquitin-conjugating enzyme
, baculovirus inhibitor of apoptosis repeat containing ubiquitin-conjugating enzyme; accccbaculoviral IAP repeat-containing 6